Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of infliximab in patients with autoimmune hepatitis.

Autor: Efe C; Department of Gastroenterology, Harran University Hospital, Şanliurfa, Turkey., Lytvyak E; Division of Gastroenterology, University of Alberta, Liver Unit, Edmonton, Alberta, Canada., Eşkazan T; Department of Gastroenterology, Cerrahpaşa School of Medicine, İstanbul, Turkey., Liberal R; Gastroenterology and Hepatology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.; World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal., Androutsakos T; Department of Pathophysiology, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Turan Gökçe D; Department of Gastroenterology, Sincan state Hospital, Ankara, Turkey., Terziroli Beretta-Piccoli B; Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Epatocentro Ticino, Lugano, Switzerland. Collaborative Partner European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Janik M; Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Full member European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Bernsmeier C; Department of Biomedicine, University of Basel, Basel, Switzerland.; University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland., Arvaniti P; Department of Medicine and Research Laboratory of Internal Medicine, Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece; Full member European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Milkiewicz P; Department of Hepatology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. Full member European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany.; Translational Medicine Group, Pomeranian Medical University in Szczecin, Poland., Batibay E; Department of Gastroenterology, Harran University Hospital, Şanliurfa, Turkey., Yüksekyayla O; Department of Gastroenterology, Harran University Hospital, Şanliurfa, Turkey., Ergenç I; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK; Collaborative Partner European Reference Network on Hepatological Diseases (ERN RARE-LIVER)., Arikan Ç; Department of Pediatric Gastroenterology and Hepatology, Koc University School of Medicine, Istanbul, Turkey., Stättermayer AF; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria; Rare Liver Disease (RALID), Affiliated Partner European Reference Network for Rare Hepatological Diseases (ERN RARE-LIVER)., Barutçu S; Department of Gastroenterology, University of Gaziantep Medical Faculty, Gaziantep, Turkey., Cengiz M; Department of Gastroenterology Gülhane Training and Research Hospital Ankara, Turkey., Gül Ö; Department of Gastroenterology, Lokman Hekim Üniversitesi Ankara Hastanesi, Ankara, Turkey., Heurgue A; Department of Hepato-Gastroenterology, CHU Reims, Reims, France., Heneghan MA; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK; Collaborative Partner European Reference Network on Hepatological Diseases (ERN RARE-LIVER)., Verma S; Brighton and Sussex Medical School, University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Purnak T; Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School, Houston, Texas, USA., Törüner M; Department of Gastroenterology, Ankara University Medical Faculty, Ankara, Turkey., Akdogan Kayhan M; Department of Gastroenterology, Ankara City Hospital, Ankara, Turkiye., Hatemi I; Department of Gastroenterology, Cerrahpaşa School of Medicine, İstanbul, Turkey., Zachou K; Department of Medicine and Research Laboratory of Internal Medicine, Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece; Full member European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Macedo G; Gastroenterology and Hepatology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.; World Gastroenterology Organization (WGO) Porto Training Center, Porto, Portugal., Drenth JPH; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, The Netherlands; Collaborative Partner European Reference Network RARE-LIVER, Hamburg, Germany., Björnsson E; Faculty of Medicine, University of Iceland, Reykjavik.; Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland., Montano-Loza AJ; Division of Gastroenterology, University of Alberta, Liver Unit, Edmonton, Alberta, Canada., Wahlin S; Department of Upper GI Diseases, Hepatology Division, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Full member European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hamburg, Germany., Higuera-de la Tijera F; Gastroenterology and Hepatology Unit, Hospital General de México, Ciudad de México, México.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.